Publications by Reshmi Rajaan

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi?db=pubmed&term=Reshmi+Rajaan%5Bauthor%5D&datetype=edat&usehistory=y&retmax=1&tool=pubfacts&email=info@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&WebEnv=MCID_67957a1230c4bd575a04319a&query_key=1&retmode=xml&retstart=-10&retmax=25&tool=pubfacts&email=info@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908 Publications by Reshmi Rajaan | LitMetric

Publications by authors named "Reshmi Rajaan"

Page 1 of 1

JAK2V617F allele burden in patients with myeloproliferative neoplasms.

Salem H Alshemmari Reshmi Rajaan Reem Ameen Mohammad A Al-Drees Marwa R Almosailleakh

Ann Hematol

May 2014

Myeloproliferative neoplasms (MPNs) are clonal malignant diseases that represent a group of conditions including polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF). The JAK2-V617F mutation is prevalent in almost all patients with MPNs and has become a valuable biomarker for diagnosis of MPNs. A different allele burden in these entities has long been noticed.

View Article and Find Full Text PDF